The role of cell-mediated immunity against influenza and its implications for vaccine evaluation

Influenza vaccines

(2022) Nadim Khalil et al.   CURRENT OPINION IN PEDIATRICS

Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain

(2022) Jesús Ruiz-Aragón et al.   Vaccines

Reactogenicity, safety, and immunogenicity of chimeric haemagglutinin influenza split-virion vaccines, adjuvanted with AS01 or AS03 or non-adjuvanted: a phase 1–2 randomised controlled trial

(2022) Nicolas Folschweiller et al.   LANCET INFECTIOUS DISEASES

Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial

(2022) Thomas G Evans et al.   LANCET INFECTIOUS DISEASES

Randomized, Double-Blind, Reference-Controlled, Phase 2a Study Evaluating the Immunogenicity and Safety of OVX836, A Nucleoprotein-Based Influenza Vaccine

(2022) Isabel Leroux-Roels et al.   Frontiers in Immunology

Promising Adjuvants and Platforms for Influenza Vaccine Development

(2021) Wandi Zhu et al.   Pharmaceutics

Antibody and Cell-Mediated Immune Responses Are Correlates of Protection against Influenza Infection in Vaccinated Older Adults

(2021) Chris P. Verschoor et al.   Vaccines

Adjuvantation of Influenza Vaccines to Induce Cross-Protective Immunity

(2021) Zhuofan Li et al.   Vaccines

T cell mediated immunity against influenza H5N1 nucleoprotein, matrix and hemagglutinin derived epitopes in H5N1 survivors and non-H5N1 subjects

(2021) Pirom Noisumdaeng et al.   PeerJ

Immunogenicity of standard, high-dose, MF59-adjuvanted, and recombinant-HA seasonal influenza vaccination in older adults

(2021) Athena P. Y. Li et al.   npj Vaccines

Safety and Immunogenicity of a Novel Intranasal Influenza Vaccine (NasoVAX): A Phase 2 Randomized, Controlled Trial

(2021) Sybil Tasker et al.   Vaccines

Influenza vaccines: Past, present, and future

(2021) Yun‐Hee Kim et al.   REVIEWS IN MEDICAL VIROLOGY

Humoral and Cellular Immune Responses in Critically Ill Influenza A/H1N1 Infected Patients

(2021) Abira Paramsothy et al.   SCANDINAVIAN JOURNAL OF IMMUNOLOGY

Transcriptional and Immunologic Correlates of Response to Pandemic Influenza Vaccine in Aviremic, HIV-Infected Children

(2021) Lesley R. de Armas et al.   Frontiers in Immunology

Innate-like Gene Expression of Lung-resident Memory CD8+ T-cells During Experimental Human Influenza: A Clinical Study

(2021) Suzanna Paterson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

The single-cell epigenomic and transcriptional landscape of immunity to influenza vaccination

(2021) Florian Wimmers et al.   CELL

Comparison of the safety and immunogenicity of a novel Matrix-M-adjuvanted nanoparticle influenza vaccine with a quadrivalent seasonal influenza vaccine in older adults: a phase 3 randomised controlled trial

(2021) Vivek Shinde et al.   LANCET INFECTIOUS DISEASES

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age

(2021) Joon Hyung Kim et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses

(2021) Nutan Mytle et al.   Viruses-Basel

Influenza virus infection expands the breadth of antibody responses through IL-4 signalling in B cells

(2021) Kosuke Miyauchi et al.   Nature Communications

The cost-effectiveness of an adjuvanted quadrivalent influenza vaccine in the United Kingdom

(2021) Michele A. Kohli et al.   Human Vaccines & Immunotherapeutics

CD49a Identifies Polyfunctional Memory CD8 T Cell Subsets that Persist in the Lungs After Influenza Infection

(2021) Emma C. Reilly et al.   Frontiers in Immunology

Human influenza virus challenge identifies cellular correlates of protection for oral vaccination

(2021) David R. McIlwain et al.   Cell Host & Microbe

Toward a universal influenza virus vaccine: Some cytokines may fulfill the request

(2021) Mojtaba Taheri et al.   CYTOKINE

Influenza Vaccines: Successes and Continuing Challenges

(2021) Tanja Becker et al.   JOURNAL OF INFECTIOUS DISEASES

Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results

(2021) Kanchanamala Withanage et al.   JOURNAL OF INFECTIOUS DISEASES

Tissue resident memory T cells in the respiratory tract

(2021) Ming Z. M. Zheng et al.   Mucosal Immunology

Influenza lineage extinction during the COVID-19 pandemic?

(2021) Marios Koutsakos et al.   NATURE REVIEWS MICROBIOLOGY

Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination

(2021) Katharina Wild et al.   Nature Communications

“World in motion” – emulsion adjuvants rising to meet the pandemic challenges

(2021) Derek T. O’Hagan et al.   npj Vaccines

Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines against Influenza B in the United States, 2011-2012 to 2016-2017

(2020) Manjusha Gaglani et al.   CLINICAL INFECTIOUS DISEASES

Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay

(2020) Veronika Chromikova et al.   VACCINE

Non-neutralizing Antibodies Directed at Conservative Influenza Antigens

(2020) E. S. Sedova et al.   Acta Naturae

Immunogenicity, Safety, and Efficacy of a Standalone Universal Influenza Vaccine, FLU-v, in Healthy Adults

(2020) Olga Pleguezuelos et al.   ANNALS OF INTERNAL MEDICINE

Systems Biological Analysis of Immune Response to Influenza Vaccination

(2020) Mario Cortese et al.   Cold Spring Harbor Perspectives in Medicine

Differential gene expression in peripheral blood mononuclear cells from children immunized with inactivated influenza vaccine

(2020) John F. Alcorn et al.   Human Vaccines & Immunotherapeutics

Lower influenza-specific cell-mediated immune responses in individuals with atopic dermatitis compared with healthy controls

(2020) Emilie Jalbert et al.   Human Vaccines & Immunotherapeutics

Baseline Levels of Influenza-Specific B Cells and T Cell Responses Modulate Human Immune Responses to Swine Variant Influenza A/H3N2 Vaccine

(2020) Lilin Lai et al.   Vaccines

Vaccination with ADCC activating HA peptide epitopes provides partial protection from influenza infection

(2020) Niloufar Kavian et al.   VACCINE

T-cell responses following Natural Influenza Infection or Vaccination in Solid Organ Transplant Recipients

(2020) Arnaud G. L’Huillier et al.   Scientific Reports

The Application of Single-Cell RNA Sequencing in Vaccinology

(2020) Andrés Noé et al.   Journal of Immunology Research

Influenza Vaccine–Induced CD4 Effectors Require Antigen Recognition at an Effector Checkpoint to Generate CD4 Lung Memory and Antibody Production

(2020) Jingya Xia et al.   JOURNAL OF IMMUNOLOGY

Measurement of Cellular Immune Response to Viral Infection and Vaccination

(2020) Wilbert Bouwman et al.   Frontiers in Immunology

Viral nucleoprotein antibodies activate TRIM21 and induce T cell immunity

(2020) Sarah L Caddy et al.   EMBO JOURNAL

The Multifaceted B Cell Response to Influenza Virus

(2019) Jonathan H. Lam et al.   JOURNAL OF IMMUNOLOGY

Evaluation of correlates of protection against influenza A(H3N2) and A(H1N1)pdm09 infection: Applications to the hospitalized patient population

(2019) Joshua G. Petrie et al.   VACCINE

Effects of Influenza Vaccination in the United States during the 2017–2018 Influenza Season

(2019) Melissa A Rolfes et al.   CLINICAL INFECTIOUS DISEASES

An indirect comparison meta-analysis of AS03 and MF59 adjuvants in pandemic influenza A(H1N1)pdm09 vaccines

(2019) Michael I. Hauser et al.   VACCINE

Imprinting and Editing of the Human CD4 T Cell Response to Influenza Virus

(2019) Sean A. Nelson et al.   Frontiers in Immunology

Influenza and Antibody-Dependent Cellular Cytotoxicity

(2019) Tarra A. Von Holle et al.   Frontiers in Immunology

Influenza imprinting in childhood and the influence on vaccine response later in life

(2019) Alyson A Kelvin et al.   Eurosurveillance

Influenza virus-specific CD4+ and CD8+ T cell-mediated immunity induced by infection and vaccination

(2019) Janina M. Jansen et al.   JOURNAL OF CLINICAL VIROLOGY

Microarray Gene Expression Dataset Re-analysis Reveals Variability in Influenza Infection and Vaccination

(2019) Lavida R. K. Rogers et al.   Frontiers in Immunology

Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children

(2019) K G-I Mohn et al.   JOURNAL OF INFECTIOUS DISEASES

Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies

(2018) Yao-Qing Chen et al.   CELL

Influenza-specific lung-resident memory T cells are proliferative and polyfunctional and maintain diverse TCR profiles

(2018) Angela Pizzolla et al.   JOURNAL OF CLINICAL INVESTIGATION

Multiplex peptide-MHC tetramer staining using mass cytometry for deep analysis of the influenza-specific T-cell response in mice

(2018) M. Fehlings et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response

(2018) Abdullah Aljurayyan et al.   JOURNAL OF VIROLOGY

Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools

(2018) Eita Sasaki et al.   PLoS One

Circulating T FH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity

(2018) Marios Koutsakos et al.   Science Translational Medicine

Towards a universal influenza vaccine: different approaches for one goal

(2018) Giuseppe A. Sautto et al.   Virology Journal

Immune responses after live attenuated influenza vaccination

(2018) Kristin G.-I. Mohn et al.   Human Vaccines & Immunotherapeutics

Adjuvanted influenza vaccines

(2018) John S. Tregoning et al.   Human Vaccines & Immunotherapeutics

A Review of DNA Vaccines Against Influenza

(2018) Leo Yi Yang Lee et al.   Frontiers in Immunology

Influenza

(2018) Florian Krammer et al.   Nature Reviews Disease Primers

Heterologous Two-Dose Vaccination with Simian Adenovirus and Poxvirus Vectors Elicits Long-Lasting Cellular Immunity to Influenza Virus A in Healthy Adults

(2018) L. Coughlan et al.   EBioMedicine

Gene expression profiling toward the next generation safety control of influenza vaccines and adjuvants in Japan

(2018) Haruka Momose et al.   VACCINE

Sex-specific patterns of gene expression following influenza vaccination

(2018) Feng Wen et al.   Scientific Reports

Basics of CD8 T-cell immune responses after influenza infection and vaccination with inactivated or live attenuated influenza vaccine

(2018) Daniil Korenkov et al.   Expert Review of Vaccines

Spec-seq unveils transcriptional subpopulations of antibody-secreting cells following influenza vaccination

(2018) Karlynn E. Neu et al.   JOURNAL OF CLINICAL INVESTIGATION

Broad CD8+ T cell cross-recognition of distinct influenza A strains in humans

(2018) Emma J. Grant et al.   Nature Communications

Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015

(2017) Danuta M. Skowronski et al.   JOURNAL OF INFECTIOUS DISEASES

Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination

(2017) Kristin G. I. Mohn et al.   JOURNAL OF INFECTIOUS DISEASES

Antibody-dependent NK cell degranulation as a marker for assessing antibody-dependent cytotoxicity against pandemic 2009 influenza A(H1N1) infection in human plasma and influenza-vaccinated transchromosomic bovine intravenous immunoglobulin therapy

(2017) Brian J. Morrison et al.   JOURNAL OF VIROLOGICAL METHODS

Differential gene expression elicited by children in response to the 2015–16 live attenuated versus inactivated influenza vaccine

(2017) Kelly Stefano Cole et al.   VACCINE

Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis

(2017) Alexander Domnich et al.   VACCINE

Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells

(2017) Samantha Reiss et al.   PLoS One

Distinct T and NK cell populations may serve as immune correlates of protection against symptomatic pandemic influenza A(H1N1) virus infection during pregnancy

(2017) Miloje Savic et al.   PLoS One

Comparisons of the Humoral and Cellular Immune Responses Induced by Live Attenuated Influenza Vaccine and Inactivated Influenza Vaccine in Adults

(2016) Daniel F. Hoft et al.   Clinical and Vaccine Immunology

2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type

(2016) Richard K. Zimmerman et al.   CLINICAL INFECTIOUS DISEASES

Cell Proliferation and Cytotoxicity Assays

(2016) Aysun Adan et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection

(2016) Anthony DiPiazza et al.   JOURNAL OF VIROLOGY

Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies

(2016) Edward A Belongia et al.   LANCET INFECTIOUS DISEASES

Efficient ex vivo analysis of CD4+ T-cell responses using combinatorial HLA class II tetramer staining

(2016) Hannes Uchtenhagen et al.   Nature Communications

The Differentiation and Protective Function of Cytolytic CD4 T Cells in Influenza Infection

(2016) Deborah M. Brown et al.   Frontiers in Immunology

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins

(2016) Hillary A. Vanderven et al.   EBioMedicine

Large Animal Models for Vaccine Development and Testing

(2015) V. Gerdts et al.   ILAR JOURNAL

Protein sequence conservation and stable molecular evolution reveals influenza virus nucleoprotein as a universal druggable target

(2015) Mustafeez Mujtaba Babar et al.   INFECTION GENETICS AND EVOLUTION

A review of the changes to the licensing of influenza vaccines in Europe

(2015) Leonoor Wijnans et al.   Influenza and Other Respiratory Viruses

Dissecting the Immune Response to MF59-adjuvanted and Nonadjuvanted Seasonal Influenza Vaccines in Children Less Than Three Years of Age

(2015) Luisanna Zedda et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Virus-specific T cells as correlate of (cross-)protective immunity against influenza

(2015) Arwen F. Altenburg et al.   VACCINE

Progress on adenovirus-vectored universal influenza vaccines

(2015) Kui Xiang et al.   Human Vaccines & Immunotherapeutics

Influenza vaccination in children primed with MF59®-adjuvanted or non-adjuvanted seasonal influenza vaccine

(2015) Timo Vesikari et al.   Human Vaccines & Immunotherapeutics

DNA vaccine for cancer immunotherapy

(2015) Benjamin Yang et al.   Human Vaccines & Immunotherapeutics

Granzyme B secretion by human memory CD4 T cells is less strictly regulated compared to memory CD8 T cells

(2014) Lin Lin et al.   BMC IMMUNOLOGY

Measuring differential gene expression with RNA-seq: challenges and strategies for data analysis

(2014) F. Finotello et al.   Briefings in Functional Genomics

DNA vaccines against tuberculosis

(2014) Nicolas Bruffaerts et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

At the centre: influenza A virus ribonucleoproteins

(2014) Amie J. Eisfeld et al.   NATURE REVIEWS MICROBIOLOGY

Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59®-adjuvanted influenza vaccine in infants and young children

(2014) Terry Nolan et al.   VACCINE

Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study

(2014) Andrew C Hayward et al.   Lancet Respiratory Medicine

Immunological assessment of influenza vaccines and immune correlates of protection

(2013) Adrian Reber et al.   Expert Review of Vaccines

Nucleoprotein of influenza A virus is a major target of immunodominant CD8+ T-cell responses

(2013) Emma Grant et al.   IMMUNOLOGY AND CELL BIOLOGY

Granzyme B ELISPOT assay to measure influenza-specific cellular immunity

(2013) Hannah M. Salk et al.   JOURNAL OF IMMUNOLOGICAL METHODS

AS03-adjuvanted versus non-adjuvanted inactivated trivalent influenza vaccine against seasonal influenza in elderly people: a phase 3 randomised trial

(2013) Janet E McElhaney et al.   LANCET INFECTIOUS DISEASES

Cellular immune correlates of protection against symptomatic pandemic influenza

(2013) Saranya Sridhar et al.   NATURE MEDICINE

Human circulating influenza-CD4+ ICOS1+IL-21+ T cells expand after vaccination, exert helper function, and predict antibody responses

(2013) F. Spensieri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans

(2012) Patrick J. Lillie et al.   CLINICAL INFECTIOUS DISEASES

Influenza vaccines: T-cell responses deserve more attention

(2012) Michael Schotsaert et al.   Expert Review of Vaccines

The history of MF59®adjuvant: a phoenix that arose from the ashes

(2012) Derek T O’Hagan et al.   Expert Review of Vaccines

Safety and Immunogenicity of Multimeric-001—a Novel Universal Influenza Vaccine

(2012) Jacob Atsmon et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms

(2012) K. Kai McKinstry et al.   JOURNAL OF CLINICAL INVESTIGATION

Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

(2012) Tom M Wilkinson et al.   NATURE MEDICINE

Fusion of the Mycobacterium tuberculosis Antigen 85A to an Oligomerization Domain Enhances Its Immunogenicity in Both Mice and Non-Human Primates

(2012) Alexandra J. Spencer et al.   PLoS One

T Cell Responses Induced by Adenoviral Vectored Vaccines Can Be Adjuvanted by Fusion of Antigen to the Oligomerization Domain of C4b-Binding Protein

(2012) Emily K. Forbes et al.   PLoS One

A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 Years

(2012) Richard D. Antrobus et al.   PLoS One

Synthetic Influenza vaccine (FLU-v) stimulates cell mediated immunity in a double-blind, randomised, placebo-controlled Phase I trial

(2012) Olga Pleguezuelos et al.   VACCINE

Comparison of ELISpot and FluoroSpot in the Analysis of Swine Flu-Specific IgG and IgA Secretion by in Vivo Activated Human B Cells

(2012) Gun Kesa et al.   Cells

Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands

(2011) R. Bodewes et al.   Clinical and Vaccine Immunology

Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection

(2011) Suzanne E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Live and Inactivated Influenza Vaccines Induce Similar Humoral Responses, but Only Live Vaccines Induce Diverse T-Cell Responses in Young Children

(2011) Daniel F. Hoft et al.   JOURNAL OF INFECTIOUS DISEASES

Different Effects of Bromodeoxyuridine and [3H]Thymidine Incorporation into DNA on Cell Proliferation, Position, and Fate

(2011) A. Duque et al.   JOURNAL OF NEUROSCIENCE

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

(2011) Steven Black et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

CD8+ T cell immunity to 2009 pandemic and seasonal H1N1 influenza viruses

(2011) Kristin Scheible et al.   VACCINE

Analysing phosphorylation-based signalling networks by phospho flow cytometry

(2010) Nikolaus G. Oberprieler et al.   CELLULAR SIGNALLING

Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1

(2010) T. K. Berthoud et al.   CLINICAL INFECTIOUS DISEASES

Vaccine Adjuvants: Putting Innate Immunity to Work

(2010) Robert L. Coffman et al.   IMMUNITY

H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses

(2010) Philippe Moris et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Development of adenoviral vector-based mucosal vaccine against influenza

(2010) Irina L. Tutykhina et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Memory CD4 T Cells Direct Protective Responses to Influenza Virus in the Lungs through Helper-Independent Mechanisms

(2010) J. R. Teijaro et al.   JOURNAL OF VIROLOGY

Cytotoxic T Lymphocytes Established by Seasonal Human Influenza Cross-React against 2009 Pandemic H1N1 Influenza Virus

(2010) W. Tu et al.   JOURNAL OF VIROLOGY

The Use of Carboxyfluorescein Diacetate Succinimidyl Ester (CFSE) to Monitor Lymphocyte Proliferation

(2010) Benjamin J. C. Quah et al.   Jove-Journal of Visualized Experiments

The relationship between human effector and memory T cells measured byex vivoand cultured ELISPOT following recent and distal priming

(2009) Stephen M. Todryk et al.   IMMUNOLOGY

EdU incorporation is an alternative non-radioactive assay to [3H]thymidine uptake for in vitro measurement of mice T-cell proliferations

(2009) Yongmao Yu et al.   JOURNAL OF IMMUNOLOGICAL METHODS

ELISPOT assays provide reproducible results among different laboratories for T-cell immune monitoring—even in hands of ELISPOT-inexperienced investigators

(2009) W. Zhang et al.   Journal of Immunotoxicology

Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population

(2009) J. A. Greenbaum et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Relationship between CD107a expression and cytotoxic activity

(2008) Esin Aktas et al.   CELLULAR IMMUNOLOGY

Correlation of Cellular Immune Responses with Protection against Culture-Confirmed Influenza Virus in Young Children

(2008) B. D. Forrest et al.   Clinical and Vaccine Immunology

Flow cytometric detection of perforin upregulation in human CD8 T cells

(2008) Adam R. Hersperger et al.   CYTOMETRY PART A

Effectiveness of Inactivated Influenza Vaccines Varied Substantially with Antigenic Match from the 2004–2005 Season to the 2006–2007 Season

(2008) Edward A. Belongia et al.   JOURNAL OF INFECTIOUS DISEASES